January 30, 2023
January 30th, 2023 – The Menarini Group, a leading Italian pharmaceutical and diagnostics company, has announced that the U.S. Food and Drug Administration
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Health Insurance
January 27, 2023
January 27, 2023 - Loxo@Lilly, the oncology unit of Eli Lilly and Company announced that the U.S. Food
and Drug Administration approved Jaypirca
January 23, 2023
January 23, 2023 - The U.S. Food and Drug Administration has approved zanubrutinib (Brukinsa),
manufactured by the biotechnology company BeiGene, which is a next-generation BTK inhibitor
January 23, 2023
January 23, 2023 - TheracosBio has announced that the U.S. Food and Drug Administration (FDA) has approved Brenzavvy (bexagliflozin), an oral sodium-glucose
January 19, 2023
January 19, 2023 - Seagen Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tukysa
January 17, 2023
FDA Approves Adacel for Immunization During Pregnancy to Help Protect Young
Infants Against Pertussis
January 17, 2023 - The U.S. Food and Drug Administration (FDA) has approved Adacel (Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis
January 15, 2023
January 15, 2023 - Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale
January 13, 2023
January 13, 2023 – The FDA signed the Agreement on Mutual Recognition between the Swiss Confederation and the U.S. Relating to Pharmaceutical Good Manufacturing Practice.